Director Global Oncology Market Access - SacTMT

MSD•Rahway, NJ
•$190,800 - $300,300•Hybrid

About The Position

The Director, Oncology Global Market Access will lead global market access strategy for one or more indications of the company’s Sac-TMT antibody drug conjugate program, spanning development, launch planning, and commercialization to optimize patient access and long-term value. The role develops actionable market access and pricing strategies that integrate payer needs, clinical development, evidence generation, commercial strategy, and changing policy and competitive dynamics. The Director translates complex market access issues into concise, decision-ready recommendations and influences decisions across a highly matrixed global organization. The role collaborates with Global and U.S. Market Access, Commercial, Clinical Development, Value & Implementation, Regulatory, Medical Affairs, Pricing, Forecasting, regional and local market access teams, and other cross-functional partners. The position is based primarily in Rahway, New Jersey, with a hybrid work arrangement and 10% travel. The employee status is regular, and relocation is not offered.

Requirements

  • BA/BS in Business, Science, Health Economics, Public Health, or a related discipline.
  • At least 5 years of relevant experience in market access, pricing and reimbursement, biopharma-related management consulting, health economics/outcomes research, commercial strategy, or related areas.
  • Strong understanding of the biopharma business model, product development, commercialization, pricing, reimbursement, and payer decision-making.
  • Experience with or strong familiarity with the U.S. market, combined with broader global market access exposure.
  • Demonstrated ability to translate complex quantitative and qualitative analyses into clear strategic recommendations.
  • Strong commercial orientation, analytical capability, and business acumen.
  • Excellent written and verbal communication skills, including the ability to distill complexity into a concise, compelling story for senior decision-makers.
  • Experience leading complex cross-functional initiatives within a matrixed organization.
  • Strong stakeholder management, collaboration, and influencing skills.
  • Ability to exercise sound strategic judgment and drive progress in ambiguous, rapidly evolving situations.
  • Skills listed: Commercial Acumen, Data Analysis, Health Economics Research, Market Access, Market Research, Oncology Marketing, Payer Reimbursement, Strategic Planning, and Strategic Thinking.

Nice To Haves

  • Advanced degree such as MBA, MPH, MS, PharmD, PhD, or another relevant postgraduate qualification.
  • Significant oncology market access and/or oncology commercialization experience.
  • Experience influencing clinical development or evidence-generation strategy from a market access perspective.
  • Experience developing global pricing strategies and supporting price, access, or revenue forecasting.
  • Experience supporting oncology launches or indication expansions across multiple major markets.
  • Experience presenting recommendations to senior leadership or enterprise governance bodies.
  • Consulting experience or equivalent demonstrated strength in structured problem solving, analytics, synthesis, and executive storytelling.

Responsibilities

  • Lead global market access strategy for assigned indications from clinical development through launch planning and commercialization.
  • Develop decision-ready recommendations connecting market access, pricing, evidence, clinical development, and commercial implications.
  • Provide market access input into clinical development and evidence-generation decisions, including patient population, endpoints, comparators, treatment setting, sequencing, and evidence gaps.
  • Lead the continued development and evolution of the Global Plan for Access, incorporating access risks and opportunities, evidence requirements, and market archetypes into asset strategy.
  • Identify value drivers and challenges to support value recognition and inform asset-level pricing strategy, considering clinical evidence, unmet need, market readiness, and competitive dynamics.
  • Lead global market access input to launch readiness and indication-expansion planning, identifying potential access barriers and developing strategies to address them.
  • Partner with U.S., regional, and local market access organizations to incorporate market realities into global strategy.
  • Assess payer trends, health technology assessment requirements, competitor developments, policy changes, pricing dynamics, and other external developments affecting access or asset value.
  • Synthesize analyses and perspectives from multiple markets and functions into strategic choices and recommendations.
  • Represent Global Market Access in cross-functional teams and governance discussions, incorporating access and pricing considerations into development and commercialization decisions.
  • Partner across Commercial, Clinical Development, CORE, Value & Implementation, Pricing, Forecasting, Medical Affairs, Regulatory, and regional and local Market Access teams.
  • Lead or coordinate analyses supporting strategic decisions, including payer research, access scenario planning, forecast assumptions, launch sequencing, and risk and opportunity assessments.
  • Communicate recommendations to senior leaders and governance forums through concise presentations and evidence-based storytelling.

Benefits

  • Medical, dental, and vision healthcare benefits.
  • Other insurance benefits for employees and family.
  • Retirement benefits, including 401(k).
  • Paid holidays.
  • Vacation.
  • Compassionate and sick days.
  • Eligible for annual bonus and long-term incentive, if applicable.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service